Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eiger Biopharma
(NQ:
EIGR
)
10.73
USD
+0.18 (+1.71%)
Official Closing Price
Updated: 5:26 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Eiger Biopharma
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Mid-Afternoon Market Update: Dow Surges 500 Points; Piedmont Lithium Shares Spike Higher
September 28, 2020
Toward the end of trading Monday, the Dow traded up 1.85% to 27,676.98 while the NASDAQ rose 1.51% to 11,078.09. The S&P also rose, ...
Tags
Market News
CALM
Earnings
From
Benzinga
50 Stocks Moving In Monday's Mid-Day Session
September 28, 2020
Gainers Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares jumped 534.5% to $6.79 after gaining 7% on Friday. Piedmont Lithium ...
Tags
IEA
TRMT
GLNG
From
Benzinga
Mid-Day Market Update: Perceptron Jumps Following Acquisition News; Inovio Pharmaceuticals Shares Plunge
September 28, 2020
Midway through trading Monday, the Dow traded up 1.59% to 27606.52 while the NASDAQ rose 1.29% to 11,053.88. The S&P also rose, ...
Tags
Earnings
CALM
Market News
From
Benzinga
Eiger Shares Nosedive On COVID-19 Study Results
September 28, 2020
Shares of micro-cap biopharma Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) were moving sharply to the downside Monday after one of ...
Tags
Market News
Biotech
Health Care
From
Benzinga
Mid-Morning Market Update: Markets Open Higher; Cal-Maine Foods Reports Narrower-Than-Expected Loss
September 28, 2020
Following the market opening Monday, the Dow traded up 1.28% to 27520.66 while the NASDAQ rose 1.04% to 11027.31. The S&P also rose, ...
Tags
Benzinga
Mid/Morning Market Update
EIGR
From
Benzinga
4 Sectors Moving Down In Monday's Pre-Market Session
September 28, 2020
Here is the sector-by-sector list of stocks moving lower in today's pre-market session: Healthcare Sun BioPharma ...
Tags
CARV
GNUS
AQST
From
Benzinga
Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19
September 28, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced results of an investigator...
From
PR Newswire
Notable Friday Option Activity: MA, IBM, EIGR
September 18, 2020
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Mastercard Inc (MA), where a total of 18,368 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
The Implied Analyst 12-Month Target For VTHR
September 11, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Eiger Bio to Participate in September 2020 Investor Conferences
September 01, 2020
From
PR Newswire
Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress™ 2020
August 31, 2020
- 96% of Patients Achieve Primary Endpoint of > 2 Log Decline in HDV RNA
From
PR Newswire
The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test
August 27, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) 10X Genomics Inc (NASDAQ: TXG) Abbott Laboratories (NYSE: ...
Tags
Biotech
Offerings
Penny Stocks
From
Benzinga
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
August 23, 2020
After seeing strength earlier, biotech stocks came under pressure in the past week. With the earnings season tapering and not much noise on the coronavirus front, the sector reacted to clinical...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
August 23, 2020
After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21. With the earnings season tapering ...
Tags
VKTX
EDAP
XBI
From
Benzinga
EIGR Trading Below Director's Recent Buy Price
August 17, 2020
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 12, Eiger BioPharmaceuticals Inc's Director,...
Tags
Stocks
From
Market News Video
IBB's Holdings Imply 20% Gain Potential
August 10, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
August 06, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial results for...
From
PR Newswire
Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences
August 03, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that management will...
From
PR Newswire
EIGR Makes Bullish Cross Above Critical Moving Average
July 20, 2020
In trading on Monday, shares of Eiger BioPharmaceuticals Inc (EIGR) crossed above their 200 day moving average of $10.69, changing hands as high as $10.84 per share. Eiger BioPharmaceuticals Inc shares...
Tags
Stocks
From
Market News Video
The Math Shows IBB Can Go To $158
June 09, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
May 29, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR) announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, state and...
From
PR Newswire
Eiger to Present at Jefferies Virtual Healthcare Conference 2020
May 26, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that Eiger management will...
From
PR Newswire
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
May 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FDA
EVOK
TBIO
From
Benzinga
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
May 19, 2020
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that the U.S. Food and...
From
PR Newswire
How I’m Playing The Red-Hot Small-Cap Biotech Stocks
May 17, 2020
Government provided liquidity has lifted all boats and removed (most of) the funding risk for dev stage biotechs. At the same time there is a recognition by investors that many biotech firms are not...
Tags
Pharma/Biotech
Stocks / Equities
ETFs
From
Blogs - TalkMarkets
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
May 13, 2020
Gainers • Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) shares moved upwards by 74.85% to $1.09 during Wednesday's pre-market ...
Tags
ACER
Healthcare Stocks Pre/Market Movers
Trading Ideas
From
Benzinga
78 Biggest Movers From Yesterday
May 12, 2020
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares climbed 66.7% to close at $3.95 on Monday after the company highlighted ...
Tags
ANGI
UAA
AMAG
From
Benzinga
54 Stocks Moving In Monday's Mid-Day Session
May 11, 2020
Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 95% to $4.62 after the company highlighted the publication of an ...
Tags
ACB
REPH
XHR
From
Benzinga
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
May 07, 2020
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial results for...
From
PR Newswire
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
April 30, 2020
- Six International, Investigator Sponsored Studies Initiating and Enrolling
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.